Patients should not attempt to accelerate dose increases independently, as this significantly raises the risk of adverse effects including nausea, vomiting, and gastrointestinal discomfort
In the ACCESS II trial, patients saw placebo-adjusted mean weight loss of about 16.3% (~39 lbs) at the 180 mg dose and 16.0% (~37 lbs) at 240 mg after 44 weeks
Mebrahtu TF et al
Lucaci AG, Notaras MJ, Kosakovsky Pond SL, Colak D (2022) The evolution of BDNF is defined by strict purifying selection and prodomain spatial coevolution, but what does it mean for human brain disease
Our capybara avatar nudges you to hit: Protein Fiber Water Exercise targets It gives simple reminders for meal planning, resistance sessions, and hydration breaks so you can manage hunger and protect muscle
Check your provider instructions, patient portal, or written documentation